Dexmedetomidine Versus Dexmedetomidine With Ketamine in Mechanically Ventilated ARDS Patients
Sponsored by Benha University
About this trial
Last updated 2 years ago
Study ID
RC 37-5-2023
Status
Recruiting
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended a year ago
What is this trial about?
The goal of this clinical trial study is to compare dexmedetomidine versus the combination of
dexmedetomidine with ketamine in hemodynamic changes and sedative effects in ARDS patients
who are in need of mechanical ventilation. The main question[s] it aims to answer are:
- [question 1]: Which dose that get the target in sedation, single and combined drugs?
- [question 2]: In which drug group that hemodynamic did not affect Participants will be
patients with ARDS that will be divided into two group the first ont will receive
dexmedetomidine 0.5 µg/kg/h mixed with ketamine 0.5 mg/kg/h and the second one will
receive dexmedetomidine at 0.5 µg/kg/h infusion only. In both the groups, studied drugs
will be titrated to achieve target sedation.
What are the participation requirements?
Inclusion Criteria
- patients with ARDS with the following:
- Those whose duration of endotracheal intubation was > 120 h
- those whose ages were 18- 70 years old
- those with acute physiology and chronic health evaluation (APACHE) II scores > 12 points.
Exclusion Criteria
- patients with a history of allergy to ketamine or dexmedetomidine
- Pregnant women,
- patients in the early stage of recovery,
- patients with unstable hemodynamics, bradycardia, sinus arrest, or other cardiac arrhythmias
Locations
Location
Status
Recruiting